Autolus Therapeutics (AUTL) Ownership - Who owns Autolus Therapeutics?

Industry: @Biotechnology
11 days until earnings call

Profile

Industry
Biotechnology
Address
191 Wood Lane
Phone
+44 2038296230
Employees
471
Web
https://www.autolus.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
1.13B
P/E Ratio
N/A
Total Cash
758.53M
Projected Growth
N/A
Total Debt
51.34M
Revenue
10.5M
Risk (Beta)
1.99
Dividend Yield
N/A
Total Cash/Share
2.85
Total Debt/Equity
N/A
Revenue/Share
0.06 USD as % of share price

Fundamentals

AUTL
Capitalization
1.13B
P/E Ratio
N/A
Risk (Beta)
1.99
Dividend Yield
N/A
Total Cash
759M
Total Cash/Share
2.85
Total Debt
51.3M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.06%
Revenue
10.5M
ROE
N/A
Book Value
582M
P/B Ratio
1.94
Cash Flow
N/A
Earnings
-1.21
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
12K
Current Ratio
18.29
Current Revenue Per Employee
21794.82
Dividends Per Share - Security
N/A
EBITDA
-155.37M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-32.50
Shares Held By Institutions
1.22B
Shares Outstanding - Current
266M
Total Liabilities
319M
Total Volume MTD
N/A
Value
N/A
Gain YTD
-34.006
View a ticker or compare two or three
AUTL
Daily Signal changed days ago
Gain/Loss if shorted
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a developer of cancer treatments

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
191 Wood Lane
Phone
+44 2038296230
Employees
471
Web
https://www.autolus.com